Colorectal Dysplasia and Carcinoma in Patients with Ulcerative Colitis and Primary Sclerosing Cholangitis

References

• Langholz E, Munkholm P, Davidsen M, Binder V. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology 1992; 103: 1444–51
   PubMed Web of Science ®Google Scholar
• Ekbom A, Helmick C, Zack M, Adami H-O. Ulcerative colitis and colorectal cancer. A population based study. N Engl J Med 1990; 323: 1228–33
   PubMed Web of Science ®Google Scholar
• Edwards F, Truelove S. The course and prognosis of ulcerative colitis. Gut 1964; 5: 1–22
   PubMed Web of Science ®Google Scholar
• Devrocde G J, Taylor W F, Sauer W G, Jackman R J, Stickler GB. Cancer risk and life expectancy of children with ulcerative colitis. N Engl J Med 1971; 285: 17–21
   PubMed Web of Science ®Google Scholar
• Greenstein A J, Sachar D B, Smith H, Pucillo A, Papatestas A E, Kreel I, et al. Cancer in universal and left-sided ulcerative colitis: factors determining risk. Gastroenterology 1979; 77: 290–4
   PubMed Web of Science ®Google Scholar
• Lennard-Jones J E. Cancer risk in ulcerative colitis: surveillance or surgery. Br J Surg 1985; 72: 84–6, Suppl
   Web of Science ®Google Scholar
• Lashner B, Silverstein M, Hanauer S. Hazard rates for dysplasia and cancer in extensive ulcerative colitis. Results from a surveillance program. Dig Dis Sci 1989; 10: 1536–41
   Google Scholar
• Aadland E, Schrumpf E, Fausa O, Elgjo K, Heilo A, Aakhus T, et al. Primary sclerosing cholangitis: a long-term follow-up study. Scand J Gastroenterol 1987; 22: 655–64
   PubMed Web of Science ®Google Scholar
• Wiesner R H, LaRusso N F. Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology 1980; 79: 2000–6
   Web of Science ®Google Scholar
• Shepherd H A, Selby W S, Chapman RGW, Nolan D, Barbatis C, McGee JO'D, et al. Ulcerative colitis and persistent liver dysfunction. Q J Med 1983; 208: 503–13
   Google Scholar
• Olsson R, Danielsson Å, Järnerot G, Lindstrom E, Lööf L, Rolny P, et al. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology 1991; 100: 1319
   PubMed Web of Science ®Google Scholar
• Wee A, Ludwig J, Coffey R, LaRusso N F, Wiesner RH. Hepatobiliary carcinoma associated with primary sclerosing cholangitis and chronic ulcerative colitis. Human Pathol 1985; 16: 719–26
   PubMed Web of Science ®Google Scholar
• Rosen C B, Nagorney D M, Wiesner R H, Coffey R J, LaRusso NF. Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg 1991; 213: 21–5
   PubMed Web of Science ®Google Scholar
• Farrant M J, Hayllar K M, Wilkinson M L, Karani J, Portmann B C, Westaby D, et al. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 1991; 100: 1710–7
   PubMed Web of Science ®Google Scholar
• Bansal P, Sonnenberg A. Sclerosing cholangitis as a risk factor for gastrointestinal cancer. Gastroenterology 1995; 4: A405
   Google Scholar
• Higashi H, Yanaga K, Marsh J, Tzakis A, Kakizoe S, Starzl T. Development of colon cancer after liver transplantation for primary sclerosing cholangitis associated with ulcerative colitis. Hepatology 1990; 11: 477–80
   PubMed Web of Science ®Google Scholar
• Bleday R, Lee E, Jessurun J, Heine J, Wong W. Increased risk of early colorectal neoplasms after hepatic transplant in patients with inflammatory bowel disease. Dis Colon Rectum 1993; 36: 908–12
   PubMed Web of Science ®Google Scholar
• Broome U, Lindberg G, Lofberg R. Primary sclerosing cholangitis in ulcerative colitis–a risk factor for development of dysplasia and DNA aneuploidy?. Gastroenterology 1992; 102: 1877–80
   PubMed Web of Science ®Google Scholar
• D'Haens G, Lahner B, Hanauer S. Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis. Am J Gastroenterol 1993; 88: 1174–8
   PubMed Web of Science ®Google Scholar
• Brentnall T, Haggit R, Rabinovitch P, Kimmey M, Bronner M, Levine D, et al. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1996; 110: 331–8
   PubMed Web of Science ®Google Scholar
• Broome U, Lofberg Veress B, Eriksson L S. Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential. Hepatology 1995; 5: 1404–8
   Google Scholar
• Gurbuz A, Giardiello F, Bayless T. Colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Dis Colon Rectum 1995; 38: 37–41
   PubMed Web of Science ®Google Scholar
• Loftus E, Jr, Sandborn W, Tremaine W, Mahoney D, Zinsmeister A, Offord K, et al. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis. Gastroenterology 1996; 110: 432–40
   PubMed Web of Science ®Google Scholar
• de Dombal F T, Watts J, Watkinson G, Goligher J C. Local complications of ulcerative colitis: stricture, pscudopolyposis and carcinoma of colon and rectum. Br Med J 1966; 1: 1442–7
   PubMed Web of Science ®Google Scholar
• Kewenter J, Ahlman H, Hulten L. Cancer risk in extensive ulcerative colitis. Ann Surg 1978; 188: 824–8
   PubMed Web of Science ®Google Scholar
• Truelove S C. Natural history of ulcerative colitis. Inflammatory bowel disease, RN Allan, MRB Keighley, J Alexander-Williams, C Hawkins. Churchill Livingstone, Birmingham 1984; 94–100
   Google Scholar
• Welin S, Welin G. The double contrast examination of the colon. Experiences with the Welin modification. Thieme, Tubingen 1976; 82–97
   Google Scholar
• Nixon J B, Riddel R H. Histopathology of ulcerative colitis. Inflammatory bowel disease, RN Allan, MRB Keighley, J Alexander-Williams, C Hawkins. Churchill Livingstone, Birmingham 1983; 194–209
   Google Scholar
• Chapman RWG, Arborgh BÅM, Rhodes J M, Summerfield J A, Dick R, Scheuer P J, et al. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut 1980; 21: 870–7
   PubMed Web of Science ®Google Scholar
• Riddel R H, Goldman H, Ransohoff D F, Appelman H D, Fenoglio C M, Haggit R C, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Human Pathol 1983; 14: 931–68
   PubMed Web of Science ®Google Scholar
• Ahnen D J. Controlled clinical trials: the controls are the key. Gastroenterology 1996; 100: 628–30
   Google Scholar
• Leidenius M, Kellokumpu I, Husa A, Rähelä M, Sipponen P. Dysplasia and cancer in long-standing ulcerative colitis–an endoscopic and histologic surveillance programme. Gut 1991; 32: 1521–5
   PubMed Web of Science ®Google Scholar
• Broomé U, Löfberg R, Lundqvist K, Veress B. Subclinical time span of inflammatory bowel disease in patients with primary sclerosing cholangitis. Dis Colon Rectum 1995; 12: 1301–5
   Google Scholar
• Hill M J, Melville D M, Lennard-Jones J E, Ritchie J K. Faecal bile acids, dysplasia and carcinoma in ulcerative colitis. Lancet 1987; 2: 185–7
   PubMed Web of Science ®Google Scholar
• Nagengast F M, Grubben MJAL, Munster IP. Role of bile acids in colorectal carcinogenesis. Eur J. Cancer 1995; 7\8: 1067–70
   Google Scholar
• Kyllonen L, Pukkala E, Eklund B. Cancer incidence in a kidney transplanted population. Transpl Int 1994–7; S350–2, Suppl 1
   Google Scholar